Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73851 - 73875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	EFNA4	1945	downregulated	Silver results in decreased expression of EFNA4 mRNA	1q21.3	A24216
Silver	Approved Investigational	EFNB3	1949	downregulated	Silver results in decreased expression of EFNB3 mRNA	17p13.1	A24216
Silver	Approved Investigational	EGF	1950	upregulated	Silver results in increased expression of EGF mRNA	4q25	A24216
Silver	Approved Investigational	EGR1	1958	upregulated	Silver analog results in increased expression of EGR1 mRNA	5q31.2	A24225
Silver	Approved Investigational	EGR1	1958	upregulated	Silver results in increased expression of EGR1 mRNA	5q31.2	A24216
Silver	Approved Investigational	EGR2	1959	upregulated	Silver results in increased expression of EGR2 mRNA	10q21.3	A24216
Silver	Approved Investigational	EGR4	1961	upregulated	Silver results in increased expression of EGR4 mRNA	2p13.2	A24216
Silver	Approved Investigational	EMX2	2018	downregulated	Silver results in decreased expression of EMX2 mRNA	10q26.11	A24216
Silver	Approved Investigational	ENPEP	2028	upregulated	Silver results in increased expression of ENPEP mRNA	4q25	A24216
Silver	Approved Investigational	EPHA2	1969	upregulated	Silver results in increased expression of EPHA2 mRNA	1p36.13	A24216
Silver	Approved Investigational	EPHA4	2043	downregulated	Silver results in decreased expression of EPHA4 mRNA	2q36.1	A24216
Silver	Approved Investigational	EPHA7	2045	downregulated	Silver results in decreased expression of EPHA7 mRNA	6q16.1	A24216
Silver	Approved Investigational	EPHX1	2052	upregulated	Silver results in increased expression of EPHX1 mRNA	1q42.12	A24218
Silver	Approved Investigational	EPOR	2057	downregulated	Silver results in decreased expression of EPOR mRNA	19p13.2	A24216
Silver	Approved Investigational	ERBB3	2065	downregulated	Silver results in decreased expression of ERBB3 mRNA	12q13.2	A24216
Silver	Approved Investigational	EXOG	9941	upregulated	Silver analog results in increased expression of EXOG mRNA	3p22.2	A24215
Silver	Approved Investigational	EXOG	9941	upregulated	Silver results in increased expression of EXOG mRNA	3p22.2	A24215
Silver	Approved Investigational	FEZF2	55079	downregulated	Silver results in decreased expression of FEZF2 mRNA	3p14.2	A24216
Silver	Approved Investigational	FGF2	2247	upregulated	Silver results in increased expression of FGF2 mRNA	4q28.1	A24216
Silver	Approved Investigational	FOS	2353	upregulated	Silver analog results in increased expression of FOS mRNA	14q24.3	A24225
Silver	Approved Investigational	FOSB	2354	downregulated	Silver analog results in decreased expression of FOSB mRNA	19q13.32	A24222
Silver	Approved Investigational	FOXP2	93986	upregulated	Silver results in increased expression of FOXP2 mRNA	7q31.1	A24216
Silver	Approved Investigational	FTH1P11	2503	upregulated	Silver analog results in increased expression of FTH1P11 mRNA	8q21.13	A24215
Silver	Approved Investigational	FTH1P12	2504	upregulated	Silver analog results in increased expression of FTH1P12 mRNA	9p22.3	A24215
Silver	Approved Investigational	FTH1P3	2498	upregulated	Silver analog results in increased expression of FTH1P3 mRNA	2p23.3	A24215

Displaying entries 73851 - 73875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability